FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Date of Report (Date of earliest event reported): July 2, 2003 MEDTOX SCIENTIFIC, INC. Delaware |
1-11394 | 95-3863205 |
(Commission File Number) | (IRS Employer Identification No.) |
402 West County Road D | |
St. Paul, Minnesota | 55112 |
(Address of principal executive offices) | (Zip Code) |
(651) 636-7466 |
Item 2. Acquisition or Disposition of Assets On July 2, 2003, the Company announced the acquisition of forensic drug testing accounts from Cox Toxicology, as described in the press release attached as Exhibit 99.1. 2 |
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
MEDTOX Scientific, Inc. | |
Date: July 2, 2003 | By: /s/ Richard J. Braun |
Name: Richard J. Braun | |
Title: Chief Executive Officer |
3 |